Who We Are
R-Health Consult (RHC) is an independent, ethical company dedicated
to improving human and planetary health. RHC provides counselling, conduct research and support implementation that helps organizations
in both the public and the private sector to address health and development.
Our team focuses on providing practical insights and research-driven recommendations to help guide public health decision-making and support the development of new tools and solutions for addressing the most pertinent public health issues, encompassing both the top-down and the bottom-up approach.
Formed by a group of experts with extensive experience and expertise in design, analysis, and implementation of public health policies, we work with stakeholders in public and private sectors to deliver knowledge and analytical products that drive positive change in health and beyond. We develop customized analytical reports, advocacy and research tools, modelling solutions, guidance notes, and thematic scoping reviews, among other.
By providing a centralized and recognizable source of support to a wide range of national and international institutions, RHC also serves as a platform to share experience, negotiate agreements, co-create innovative solutions, and implement sustainable, cost-effective policies and technologies to support public health and sustainable development.
RHC has expertise in various academic, technical and professional disciplines with extensive experience in working with the UN, national policymakers, NGOs, and research and academic institutions. In addition, RHC provides networking tools to gather and exchange the latest and most relevant information and evidence-informed findings on most pertinent and strategic developments in the domains of public health, medical sciences, pharmacology, social health security, and health innovation.
Why Choose Us
We specialize in combining data-driven insights with forward-looking ideas
to improve the ways in which our societies preserve, enjoy, and promote health.
Quality
We combine outstanding expertise with rigorous, professional approach to output delivery.
Efficiency
We are impact-oriented and prioritize workflows and strategies that allow to deliver results, even when inputs are limited.
Comprehensive approach
We think holistically, and leverage opportunities for synergy and integration.
Forward-looking analysis
We go beyond what works today and try to envision what will guarantee success tomorrow.
Innovation
Many think outside the box.
We think outside the tesseract.
Communication
We excel in transforming complex evidence in compelling messages that resonate with target stakeholders.
"Health matters — so do the decisions that influence it"
We are committed to changing the ways in which policy-makers, businesses, and individuals perceive health and respond to the global and local challenges that put public and individual health at risk.
Our expertise is broad and strengthened by decades of experience working with public health institutions, private enterprises, health researchers and practitioners, international organizations, and NGOs. We are keen to put our capacity and knowledge to work to contribute to better health and development of people and societies.
Our Experts
Health economist
Dr Yong Yi Lee
Dr Yong Yi Lee is a distinguished Research Fellow within the Health Economics Group at Monash University's School of Public Health and Preventive Medicine (SPHPM). He is also an adjunct fellow at The University of Queensland (UQ) School of Public Health and the Queensland Centre for Mental Health Research (QCMHR). Dr Lee's expertise lies in the application of cutting-edge economic evaluation methods and modeling techniques to assess the cost-effectiveness of interventions for mental health conditions and non-communicable diseases. His impactful contributions extend to being a health economics consultant for the World Health Organization, providing invaluable insights on mental health investment cases across the globe.
Scientific advisor
Dr Anna Kontsevaya
Dr Anna Kontsevaya serves as the Deputy Director of Science and Analytics at the National Medical and Research Center for Therapy and Preventive Medicine. With a profound background in medical sciences and health economics from the London School of Economics (UK), she is a leading authority in public health research, primary prevention, and health economics. Dr Kontsevaya's consultancy experience with the World Health Organization and the United Nations Development Programme since 2013 further exemplifies her dedication to health economy, specifically in non-communicable diseases and mental health investment cases.
Researcher, report writer
David Lyle Dela Pena
David Lyle Dela Pena, a Bachelor of Arts in International Relations graduate, possesses a remarkable skill set ranging from qualitative to quantitative research. His dedication to research and administration underpins his instrumental contributions to the team.
Researcher, report writer, health economist
Jenna Rupieper
Jenna Rupieper, an accomplished health economist, embarks on a mission to catalyze public-private partnerships in the realm of global health. Holding an MPH and a PhD in Epidemiology and Health Economics, her expertise lies in generating evidence for regional and global investment cases, harmonizing stakeholder visions, and spearheading innovative solutions that add value to health systems.
Health economist, researcher
Dinara Mukaneeva
Dinara Mukaneeva, a seasoned researcher, collaborates closely with the World Health Organization and the United Nations Development Programme to underpin investment cases for non-communicable diseases and mental health. Her involvement spans methodologies for tobacco cessation, alcohol control, and online tools for economic efficiency forecasting, underscoring her substantial impact on evidence-driven decision-making.
Cardiologist, clinical advisor
Alexandra Antsiferova
Alexandra Antsiferova, an adept cardiologist and clinical advisor, combines her clinical insights with robust research capabilities. Her contributions to the department of public health at the National Medical and Research Center for Therapy and Preventive Medicine reflect her commitment to bridging medical guidelines with clinical practice
Consultant
Dr Ilaria Corazza
Dr Ilaria Corazza, armed with a PhD in Healthcare Management and an economics background, brings invaluable expertise to healthcare performance management and evaluation, particularly in low- and middle-income countries. Her close collaboration with the World Health Organization and the UN Interagency Task Force on NCDs (UNIATF) showcases her pivotal role in shaping effective health strategies.
Consultant
Dr Lambed Tatah
Lambed Tatah, an esteemed epidemiologist, specializes in gauging policy impacts on non-communicable diseases (NCDs). With a decade of experience, his research illuminates the complex interplay between urban transport, physical activity, and NCDs, thus contributing to the enhancement of global health outcomes.
Digital health specialist
Nicole Marchetti
Nicole Marchetti, a dedicated digital health specialist, leverages her academic qualifications to support the development of innovative preventive mobile health campaigns. Her qualitative research acumen fosters a deep understanding of health contexts in developing nations, underpinning strategic interventions.
Report writer, researcher
Dr Subheree Ray Kale
Dr Subhasree Ray Kale, a Ph.D. holder in Food Science and Nutrition, boasts extensive experience in public health and clinical nutrition. Specializing in non-communicable diseases, preventive health, and sustainable food systems, her expertise is pivotal in shaping holistic health solutions.
Intern, health economist
Caroline Manuela Hartanto
Having a dentist degree, Caroline practiced in clinical setting for 2 years before decided to take another challenge. She is currently studying to become a health economist in Sweden and has a keen interest in both economic modelling and policy evaluation for public health interventions from economic perspective.
Intern
Yangxu Lin
Yangxu Lin is studying MSc Economics for Development at the University of Oxford (UK). Before that, she completed the MITx MicroMasters programme in Data, Economics and Design of Policy – International Development Track with excellent outcomes, and obtained BSc Economics from both the University of Liverpool (UK) and Xi’an Jiaotong-Liverpool University (Suzhou, China) with multiple prizes and scholarships. Upon graduation, she was awarded the prize of Best Overall Academic Performance in Undergraduate Economics Programme for her extraordinary academic achievement throughout the four years. Besides multi-cultural academics, Yangxu has gained experience in both public and private sectors. She exposed herself in various food and healthcare-related projects/cases in private consulting firms. Having deeply participated in investment case studies related to health taxes (with UNDP), road safety and so on in LMICs, she becomes more committed to leveraging her expertise along with research and analytical skills to empower evidence-based health policy and interventions and strive for human development.
Researcher
Dr Abdul Cadri
Abdul is a public health specialist with keen interest in implementation research. With academic trainings from University of Health and Allied Science - Ghana, University of Ghana, and McGill University in Canada, he brings in an incredibly broad skillset to his research activities that includes well-honed abilities in qualitative and quantitative methodologies, participatory approaches, and stakeholder engagement.
Digital health specialist
Dr Orsolya Ihasz
Senior academic in economics of innovation and social impact with a strong public health focus. Strategic advisor to the WHO and ITU on scaling mHealth interventions for tackling NCDs globally with over 15 years’ experience in entrepreneurship development and technology commercialization across the UK and Europe. Current activities include advising governments on building innovation ecosystems and scaling digitally enabled social innovation by applying a ‘mission-led’ approach.
Researcher
Dr Borja del Pozo Cruz
Dr Borja del Pozo Cruz is a leading scientist in Lifestyle, Preventive Medicine, and Public Health. He is currently Principal Investigator in Health under the EMERGIA program at the University of Cádiz, Spain. Previously, he was an Associate Professor at Southern Denmark University, where he now holds an honorary professorship. He is also a visiting professor fellow at the University of Jyväskylä. Past roles include Senior Research Fellow at the Australian Catholic University, Senior Lecturer at Auckland University, and Assistant Lecturer at the University of Seville. Dr del Pozo was listed in the 2022 and 2023 Stanford University rankings of the top 2% scientists globally. His research explores the interactions between sleep, sedentary behaviour, and physical activity, and how lifestyle behaviours can be leveraged to improve public health. His work has significantly advanced understanding in the field.
Researcher
Krista Kruja
Krista Kruja is experienced in delivering complex, multi-stakeholder projects relating to health systems research and decision-making. She has convened donors and stakeholders into working groups to identify strategies to improve investment in and evaluation of health systems strengthening and has led initiatives for the World Health Organization, including coordinating the establishment of an evidence base around access to novel medicines and consulting with stakeholders to identify key areas for policy action, delivering tools and related consultations to support national decision-makers with implementing public health measures during health emergencies, and managing a multi-faceted programme focused on building capacity for health emergency research and decision-making in Indonesia. Krista holds an MSc in Health Policy, Planning, and Financing from the London School of Hygiene and Tropical Medicine and London School of Economics and Political Science.
Intern
Pierpaolo Sesana
With a nursing background, Pierpaolo worked for three years in the hospital setting before moving to Sweden for a Master of Medical Science in Bioentrepreneurship at Karolinska Institutet. Driven by a sincere desire to improve patient well-being, he developed a keen interest in market access and policy during his academic journey. Pierpaolo combines solid clinical knowledge with experience in the pharmaceutical industry in the obesity field.
Consultant
Dr Sok Cin Tye
Dr. Tye Sok Cin is a postdoctoral researcher at Joslin Diabetes Center, Harvard Medical School, specializing in precision medicine for diabetes and cardiometabolic disorders. Her work bridges clinical practice and research, focusing on treatment heterogeneity and disease stratification to improve outcomes for non-communicable diseases. She earned her Ph.D. from the University of Groningen and has received several honors, including the Andrew P. Goldberg Early Career Award, the Young Asian Research Fellowship (Japan), and an EU Horizon 2020 Marie Skłodowska-Curie Grant.
Intern
Amir Hosseinzadeh
Amir is an experienced pharmacist within the pharmaceutical industry and a graduate in Bioentrepreneurship from Karolinska Institutet, with a proven track record in root-cause analysis and problem-solving. With a strong desire for market access, he contributed to drug affordability and availability projects by proposing solutions during his academic journey. Amir blends his knowledge of the pharmaceutical landscape with business acumen aimed at addressing global health challenges.
Intern
Xuan Zhang
Xuan is a dedicated researcher with a Master’s degree in Global Health from Karolinska Institutet and a Bachelor’s degree in Nursing from Guangzhou University of Chinese Medicine. With a strong foundation in clinical care and public health, she has contributed to impactful research projects, particularly in the fields of mental and reproductive health. She has actively participated in collaborative projects with institutions such as KTH Royal Institute of Technology and the University of North Carolina-China, contributing to global health initiatives through hands-on research. Fluent in multiple languages and skilled in data analysis, she is committed to advancing public health solutions through innovation and compassion.
Intern
Chekeh Mboge
Chekeh is a researcher with a background in pharmaceutical market intelligence, now specialising in qualitative healthcare research & policy analysis. She holds a bachelor's degree in Biomedical Science from King’s College London and recently completed an MSc in Health Management at City St George’s, University of London. Chekeh’s current research focus is evidence-based digital interventions for health system strengthening and policy on anti-microbial resistance & mental health.
Health economist
Artem Antonov
Artem Antonov holds MSc in Health Economics, seamlessly combines his research project management acumen with his role as a fellow researcher. His involvement in cost-effectiveness analysis, epidemiological modeling, and methodological support underscores his dedication to evidence-based decision-making.